2021 - Medical Device Single Audit Program [MDSAP] Implementation & Participating Country Regulatory Processes: U.S., Canada, Brazil, Australia and Japan
Date2021-02-24
Deadline2021-02-14
VenueVirtual Seminar, USA - United States
KeywordsGMP audit; Mdsap audit; Device classification
Topics/Call fo Papers
The Medical Device Single Audit Program (MDSAP)
Device Classification
Licensing Pathways
Medical Device GMP
Inspections
Device Labeling
License Holder Responsibilities
Timelines and Fees
Country Specific Cultural Considerations and Challenges
Adverse Event Reporting
Device Classification
Licensing Pathways
Medical Device GMP
Inspections
Device Labeling
License Holder Responsibilities
Timelines and Fees
Country Specific Cultural Considerations and Challenges
Adverse Event Reporting
Other CFPs
- Coping with FDA Import Delays, including COVID-19, Expedited Imports and Detentions
- Navigating the Medical Device Post-Market Maze and Challenges during COVID-19 Pandemic - Learn what FDA is really thinking on regulation and guidance documents
- First International Conference on ICT for Health, Accessibility and Wellbeing (IHAW 2021)
- 2nd International Conference on Software Engineering and Managing Information Technology (SEMIT 2021)
- Biocompatibility Testing: What You Need to Know
Last modified: 2021-02-06 21:12:37